Arkolith/Insider Trading/CKPT/Form 4

Oliviero James F III

CEO, President and Director, DirectorCheckpoint Therapeutics, Inc. (CKPT) · full profile →Form 4 · filed Jun 28, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$50K
Net Open-Market Flow
-$50K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 26, 2024Gift(G)38K—$01.9M
Jun 26, 2024Sell(S)25K$2.05$50K2.0M

Transaction Codes

G
Gift
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-24-076442) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML